Inhaler
Latest AstraZeneca AB Patents:
- IRAK4 inhibitors
- Pharmaceutical composition
- Methods of treating chronic kidney disease with dapagliflozin
- Pharmaceutical compositions comprising (2S)-n-{(1S)-1-cyano-2-[4-(3-methyl-2-oxo-2,3-dihydro-1,3-benzoxazol-5-yl)phenyl]ethyl}-1,4-oxazepane-2-carboxamide
- Arginase inhibitors and methods of use thereof
FIG. 1 is a perspective view of the inhaler with the cover closed.
FIG. 2 shows a bottom elevation of the inhaler with the cover closed.
FIG. 3 shows a rear elevation of the inhaler with the cover closed.
FIG. 4 shows a top elevation of the inhaler with the cover closed.
FIG. 5 shows a side elevation of the inhaler with the cover closed.
FIG. 6 shows a front elevation of the inhaler with the cover closed.
FIG. 7 shows a perspective view of the inhaler with the cover open.
FIG. 8 shows a front elevation of the inhaler with the cover open.
FIG. 9 shows a side elevation of the inhaler with the cover open.
FIG. 10 shows a bottom elevation of the inhaler with the cover open.
FIG. 11 shows a top elevation of the inhaler with the cover open; and,
FIG. 12 shows a rear elevation of the inhaler with the cover open.
Claims
The ornamental design for an inhaler, as shown and described.
Type: Grant
Filed: Sep 25, 2000
Date of Patent: Oct 23, 2001
Assignee: AstraZeneca AB
Inventors: Søren Christrup (Struer), Anders Geert-Jensen (Höjberg), Mikal Jørgensen (Århus), Jørgen Rasmussen (Struer), Hugo Dines Schmidt (Århus)
Primary Examiner: Ian Simmons
Attorney, Agent or Law Firm: Nixon & Vanderhye
Application Number: 29/130,006
International Classification: 2902;
